Thyromimetics Patent - Autobahn Therapeutics
Summary
USPTO granted patent US12590072B2 to Autobahn Therapeutics, Inc. covering thyromimetic compounds for treating neurodegenerative disorders and fibrotic diseases. The patent (20 claims) names inventors Thomas von Geldern and Bradley Backes, with original filing date June 17, 2021. This is a routine patent grant notice with no compliance obligations.
What changed
USPTO issued patent US12590072B2 to Autobahn Therapeutics, Inc. for thyromimetic compounds useful in treating neurodegenerative and fibrotic diseases. The patent contains 20 claims and covers both the compounds and pharmaceutical compositions containing them. Inventors are Thomas von Geldern and Bradley Backes.
Patent grants do not impose compliance obligations on other entities. Competitors developing similar thyromimetic compounds should review this patent to assess potential freedom-to-operate issues or consider licensing. No deadlines, fees, or regulatory responses are required from the general public.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Thyromimetics
Grant US12590072B2 Kind: B2 Mar 31, 2026
Assignee
AUTOBAHN THERAPEUTICS, INC.
Inventors
Thomas von Geldern, Bradley Backes
Abstract
Disclosed herein are thyromimetic compounds having utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their preparation.
CPC Classifications
C07D 235/075 C07D 261/12 C07C 39/367
Filing Date
2021-06-17
Application No.
18002035
Claims
20
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.